Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Cowen to hold a virtual summit » 10:30
05/26/21
05/26
10:30
05/26/21
10:30
M

Macy's

$18.65 /

+0.68 (+3.78%)

, MYTE

Mytheresa

$31.98 /

+0.45 (+1.43%)

, BBW

Build-A-Bear

$11.00 /

+0.88 (+8.70%)

, JWN

Nordstrom

$33.35 /

-3.15 (-8.63%)

, RVLV

Revolve Group

$53.27 /

+2.46 (+4.84%)

, REAL

RealReal

$16.97 /

+0.44 (+2.66%)

, POSH

Poshmark

$43.40 /

+0.45 (+1.05%)

2nd Annual New Retail…

2nd Annual New Retail Ecosystem CEO Virtual Summit: Innovation & Digitization will be held on May 26.

ShowHide Related Items >><<
RVLV Revolve Group
$53.27 /

+2.46 (+4.84%)

REAL RealReal
$16.97 /

+0.44 (+2.66%)

POSH Poshmark
$43.40 /

+0.45 (+1.05%)

MYTE Mytheresa
$31.98 /

+0.45 (+1.43%)

M Macy's
$18.65 /

+0.68 (+3.78%)

JWN Nordstrom
$33.35 /

-3.15 (-8.63%)

BBW Build-A-Bear
$11.00 /

+0.88 (+8.70%)

M Macy's
$18.65 /

+0.68 (+3.78%)

05/19/21 Morgan Stanley
Macy's price target raised to $17 from $11 at Morgan Stanley
05/19/21 Deutsche Bank
Macy's price target raised to $23 from $16 at Deutsche Bank
05/19/21 Citi
Macy's remains 'structurally challenged,' says Citi
05/19/21 Evercore ISI
Evercore ISI boosts Macy's price target to $27, adds to Tactical Outperform list
MYTE Mytheresa
$31.98 /

+0.45 (+1.43%)

05/24/21 JPMorgan
Mytheresa price target raised to $39 from $38 at JPMorgan
05/19/21 Morgan Stanley
Mytheresa price target raised to $42 from $37 at Morgan Stanley
02/16/21
Fly Intel: Top five analyst initiations
02/16/21 Jefferies
Mytheresa initiated with a Buy at Jefferies
BBW Build-A-Bear
$11.00 /

+0.88 (+8.70%)

JWN Nordstrom
$33.35 /

-3.15 (-8.63%)

05/26/21 Deutsche Bank
Nordstrom price target lowered to $40 from $42 at Deutsche Bank
05/26/21 Barclays
Nordstrom price target raised to $20 from $19 at Barclays
05/17/21 JPMorgan
Nordstrom price target raised to $42 from $37 at JPMorgan
03/12/21
Fly Intel: Top five analyst initiations
RVLV Revolve Group
$53.27 /

+2.46 (+4.84%)

05/07/21 Piper Sandler
Revolve Group price target raised to $58 from $53 at Piper Sandler
04/26/21 KeyBanc
Etsy downgraded to Sector Weight on valuation at KeyBanc
04/12/21 Cowen
Revolve Group price target raised to $56 from $45 at Cowen
04/07/21 Piper Sandler
Revolve Group price target raised to $53 from $45 at Piper Sandler
REAL RealReal
$16.97 /

+0.44 (+2.66%)

05/11/21 BTIG
RealReal downgraded to Neutral from Buy at BTIG
05/11/21 BTIG
RealReal downgraded to Neutral from Buy at BTIG
05/04/21 Piper Sandler
Piper Sandler a buyer of RealReal into the Q1 results
04/13/21 KeyBanc
eBay's watch selling fee increase 'favorable' for RealReal, says KeyBanc
POSH Poshmark
$43.40 /

+0.45 (+1.05%)

05/17/21 JMP Securities
Poshmark price target lowered to $57 from $85 at JMP Securities
05/13/21 MKM Partners
Poshmark price target lowered to $50 from $83 at MKM Partners
05/13/21 Morgan Stanley
Poshmark price target lowered to $47 from $52 at Morgan Stanley
05/13/21 Raymond James
Poshmark price target lowered to $58 from $68 at Raymond James
RVLV Revolve Group
$53.27 /

+2.46 (+4.84%)

REAL RealReal
$16.97 /

+0.44 (+2.66%)

POSH Poshmark
$43.40 /

+0.45 (+1.05%)

M Macy's
$18.65 /

+0.68 (+3.78%)

JWN Nordstrom
$33.35 /

-3.15 (-8.63%)

BBW Build-A-Bear
$11.00 /

+0.88 (+8.70%)

  • 21
    Jan
  • 14
    Jan
  • 18
    Nov
  • 11
    Sep
RVLV Revolve Group
$53.27 /

+2.46 (+4.84%)

MYTE Mytheresa
$31.98 /

+0.45 (+1.43%)

M Macy's
$18.65 /

+0.68 (+3.78%)

JWN Nordstrom
$33.35 /

-3.15 (-8.63%)

RVLV Revolve Group
$53.27 /

+2.46 (+4.84%)

REAL RealReal
$16.97 /

+0.44 (+2.66%)

POSH Poshmark
$43.40 /

+0.45 (+1.05%)

MYTE Mytheresa
$31.98 /

+0.45 (+1.43%)

M Macy's
$18.65 /

+0.68 (+3.78%)

JWN Nordstrom
$33.35 /

-3.15 (-8.63%)

BBW Build-A-Bear
$11.00 /

+0.88 (+8.70%)

RVLV Revolve Group
$53.27 /

+2.46 (+4.84%)

POSH Poshmark
$43.40 /

+0.45 (+1.05%)

M Macy's
$18.65 /

+0.68 (+3.78%)

JWN Nordstrom
$33.35 /

-3.15 (-8.63%)

Recommendations
Mytheresa price target raised to $39 from $38 at JPMorgan » 07:34
05/24/21
05/24
07:34
05/24/21
07:34
MYTE

Mytheresa

$32.00 /

-0.015 (-0.05%)

JPMorgan analyst Matthew…

JPMorgan analyst Matthew Boss raised the firm's price target on Mytheresa to $39 from $38 and keeps an Overweight rating on the shares after hosting meetings with management. Management has "clear confidence" in the multi-year sustainability of the luxury consumer's online shift and the company's ability deliver 22%-25% annual revenue growth, Boss tells investors in a research note.

ShowHide Related Items >><<
MYTE Mytheresa
$32.00 /

-0.015 (-0.05%)

MYTE Mytheresa
$32.00 /

-0.015 (-0.05%)

05/19/21 Morgan Stanley
Mytheresa price target raised to $42 from $37 at Morgan Stanley
02/16/21
Fly Intel: Top five analyst initiations
02/16/21 Jefferies
Mytheresa initiated with a Buy at Jefferies
02/16/21 Credit Suisse
Mytheresa initiated with an Outperform at Credit Suisse
  • 21
    Jan
MYTE Mytheresa
$32.00 /

-0.015 (-0.05%)

MYTE Mytheresa
$32.00 /

-0.015 (-0.05%)

Over a month ago
Recommendations
Mytheresa price target raised to $42 from $37 at Morgan Stanley » 08:05
05/19/21
05/19
08:05
05/19/21
08:05
MYTE

Mytheresa

$29.35 /

+0.95 (+3.35%)

Morgan Stanley analyst…

Morgan Stanley analyst Kimberly Greenberger raised the firm's price target on Mytheresa to $42 from $37 and keeps an Overweight rating on the shares following Q3 results and a raised fiscal year outlook that she said "bolstered" her thesis. Mytheresa is showing "exceptional execution" at a time when the Covid-induced luxury shift online presented a "unique customer acquisition opportunity," argues Greenberger, who also views this shift as likely to be more durable than initially expected.

ShowHide Related Items >><<
MYTE Mytheresa
$29.35 /

+0.95 (+3.35%)

MYTE Mytheresa
$29.35 /

+0.95 (+3.35%)

02/16/21
Fly Intel: Top five analyst initiations
02/16/21 Jefferies
Mytheresa initiated with a Buy at Jefferies
02/16/21 Credit Suisse
Mytheresa initiated with an Outperform at Credit Suisse
02/16/21 Morgan Stanley
Mytheresa initiated with an Overweight at Morgan Stanley
  • 21
    Jan
MYTE Mytheresa
$29.35 /

+0.95 (+3.35%)

MYTE Mytheresa
$29.35 /

+0.95 (+3.35%)

Conference/Events
Cowen to hold a virtual summit » 08:58
04/06/21
04/06
08:58
04/06/21
08:58
FTCH

Farfetch

$49.74 /

-3.14 (-5.94%)

, WMT

Walmart

$139.42 /

+3.87 (+2.86%)

, MYTE

Mytheresa

$26.50 /

-0.69 (-2.54%)

2nd Annual Consumer…

2nd Annual Consumer Platforms for the Next Generation Virtual Summit will be held on April 6.

ShowHide Related Items >><<
WMT Walmart
$139.42 /

+3.87 (+2.86%)

MYTE Mytheresa
$26.50 /

-0.69 (-2.54%)

FTCH Farfetch
$49.74 /

-3.14 (-5.94%)

FTCH Farfetch
$49.74 /

-3.14 (-5.94%)

02/23/21 Credit Suisse
Farfetch price target raised to $85 from $53 at Credit Suisse
12/22/20 Wells Fargo
Farfetch price target raised to $60 from $50 at Wells Fargo
12/08/20 JPMorgan
Farfetch price target raised to $68 from $62 at JPMorgan
11/17/20
Fly Intel: Top five analyst initiations
WMT Walmart
$139.42 /

+3.87 (+2.86%)

04/06/21 Morgan Stanley
Walmart+ membership 'seems to have stagnated,' says Morgan Stanley
03/16/21 MKM Partners
Walmart price target lowered to $141 from $154 at MKM Partners
02/23/21 Evercore ISI
Walmart accelerating change with investments, says Evercore ISI
02/19/21 Morgan Stanley
Walmart terminal value rising with investments, says Morgan Stanley
MYTE Mytheresa
$26.50 /

-0.69 (-2.54%)

02/16/21
Fly Intel: Top five analyst initiations
02/16/21 Jefferies
Mytheresa initiated with a Buy at Jefferies
02/16/21 Credit Suisse
Mytheresa initiated with an Outperform at Credit Suisse
02/16/21 Morgan Stanley
Mytheresa initiated with an Overweight at Morgan Stanley
WMT Walmart
$139.42 /

+3.87 (+2.86%)

FTCH Farfetch
$49.74 /

-3.14 (-5.94%)

  • 06
    Apr
  • 21
    Jan
WMT Walmart
$139.42 /

+3.87 (+2.86%)

MYTE Mytheresa
$26.50 /

-0.69 (-2.54%)

FTCH Farfetch
$49.74 /

-3.14 (-5.94%)

WMT Walmart
$139.42 /

+3.87 (+2.86%)

MYTE Mytheresa
$26.50 /

-0.69 (-2.54%)

FTCH Farfetch
$49.74 /

-3.14 (-5.94%)

WMT Walmart
$139.42 /

+3.87 (+2.86%)

FTCH Farfetch
$49.74 /

-3.14 (-5.94%)

Over a quarter ago
Hot Stocks
Fly Intel: Top five weekend stock stories » 20:01
03/07/21
03/07
20:01
03/07/21
20:01
GE

General Electric

$13.59 /

+0.03 (+0.22%)

, AER

AerCap

$50.82 /

+0.825 (+1.65%)

, MSFT

Microsoft

$231.58 /

+4.72 (+2.08%)

, NHIC

NewHold Investment Corp.

$10.00 /

+0.03 (+0.30%)

, LOW

Lowe's

$158.56 /

+4.865 (+3.17%)

, DIS

Disney

$189.90 /

+2.18 (+1.16%)

, MYTE

Mytheresa

$27.08 /

+1.9 (+7.55%)

, VRTX

Vertex Pharmaceuticals

$211.97 /

+4.14 (+1.99%)

, AVGO

Broadcom

$449.96 /

+6.555 (+1.48%)

, CSCO

Cisco

$46.22 /

+1.595 (+3.57%)

, QCOM

Qualcomm

$129.75 /

+2.0799 (+1.63%)

, TXN

Texas Instruments

$167.83 /

+4.58 (+2.81%)

Catch up on the…

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. General Electric (GE) is nearing a $30B-plus deal to combine its aircraft-leasing business with Ireland's AerCap (AER), The Wall Street Journal's Cara Lombardo and Emily Glazer reported, citing people familiar with the matter. Though details of how the deal would be structured couldn't be learned, it is expected to have a valuation of more than $30B, some of the people said. An announcement is expected Monday, assuming the talks don't fall apart, the authors added. 2. Evolv Technology is combining with a special-purpose acquisition company to go public in a deal that values the crowd-safety company at about $1.7B, The Wall Street Journal's Amrith Ramkumar reported. Backed by investors including Microsoft (MSFT) co-founder Bill Gates and former Florida Gov. Jeb Bush, Evolv is merging with the SPAC NewHold Investment Corp. (NHIC), the author noted. 3. Lowe's (LOW) was a lockdown winner and investors are having second thoughts about its stock now that reopening looms, but Lowe's is far more than just a COVID-19 play, Teresa Rivas wrote in this week's edition of Barron's. Concerns are probably overblown and with COVID receding, Lowe's is set to become a more profitable company, while housing might be more resilient than it's given credit for, the author contended. 4. Disney's (DIS) "Raya and the Last Dragon" easily won the weekend box office, the biggest since pandemic shut down theaters as New York City was finally allowed to reopen at 25% capacity. The movie sports an A CinemaScore and took in an estimated $8.6M in its North American debut. Overseas, "Raya and the Last Dragon" earned $17.6M from 32 markets for a global total of $26.2M. 5. Mytheresa (MYTE), Vertex Pharmaceuticals (VRTX), Broadcom (AVGO), Cisco (CSCO), Qualcomm (QCOM) and Texas Instruments (TXN) saw positive mentions in this week's edition of Barron's.

ShowHide Related Items >><<
VRTX Vertex Pharmaceuticals
$211.97 /

+4.14 (+1.99%)

TXN Texas Instruments
$167.83 /

+4.58 (+2.81%)

QCOM Qualcomm
$129.75 /

+2.0799 (+1.63%)

MYTE Mytheresa
$27.08 /

+1.9 (+7.55%)

MSFT Microsoft
$231.58 /

+4.72 (+2.08%)

LOW Lowe's
$158.56 /

+4.865 (+3.17%)

GE General Electric
$13.59 /

+0.03 (+0.22%)

DIS Disney
$189.90 /

+2.18 (+1.16%)

CSCO Cisco
$46.22 /

+1.595 (+3.57%)

AVGO Broadcom
$449.96 /

+6.555 (+1.48%)

AER AerCap
$50.82 /

+0.825 (+1.65%)

GE General Electric
$13.59 /

+0.03 (+0.22%)

03/04/21 Morgan Stanley
General Electric price target raised to $17 from $13 at Morgan Stanley
03/02/21 Barclays
Danaher started at Overweight at Barclays on GE biopharma business potential
02/22/21 Goldman Sachs
General Electric price target raised to $15 at Goldman Sachs after meetings
01/28/21 Barclays
General Electric price target raised to $13 from $12 at Barclays
AER AerCap
$50.82 /

+0.825 (+1.65%)

01/26/21 Cowen
AerCap price target raised to $54 from $50 at Cowen
12/21/20 Deutsche Bank
AerCap price target raised to $55 from $44 at Deutsche Bank
12/10/20 Barclays
AerCap price target raised to $58 from $42 at Barclays
11/24/20
Fly Intel: Top five analyst upgrades
MSFT Microsoft
$231.58 /

+4.72 (+2.08%)

03/05/21 Morgan Stanley
Microsoft price target raised to $290 from $285 at Morgan Stanley
03/03/21 Citi
Microsoft assumed with a Buy at Citi
02/16/21 Wedbush
Microsoft price target raised to $300 from $285 at Wedbush
02/16/21 UBS
Workday price target raised to $280 from $235 at UBS
NHIC NewHold Investment Corp.
$10.00 /

+0.03 (+0.30%)

LOW Lowe's
$158.56 /

+4.865 (+3.17%)

02/25/21
Fly Intel: Top five analyst upgrades
02/25/21 Gordon Haskett
Gordon Haskett upgrades Lowe's to Buy, sees ability to 'stomp the comp'
02/25/21 Gordon Haskett
Lowe's upgraded to Buy from Accumulate at Gordon Haskett
02/24/21 RBC Capital
Lowe's price target raised to $206 after quarterly results at RBC Capital
DIS Disney
$189.90 /

+2.18 (+1.16%)

02/25/21 Craig-Hallum
Magnite price target raised to $72 from $63 at Craig-Hallum
02/25/21 Citi
Disney price target raised to $230 from $205 at Citi
02/23/21 Credit Suisse
SeaWorld price target raised to $52 from $34 at Credit Suisse
02/17/21 Argus
Disney price target raised to $225 from $200 at Argus
MYTE Mytheresa
$27.08 /

+1.9 (+7.55%)

02/16/21
Fly Intel: Top five analyst initiations
02/16/21 Jefferies
Mytheresa initiated with a Buy at Jefferies
02/16/21 Credit Suisse
Mytheresa initiated with an Outperform at Credit Suisse
02/16/21 Morgan Stanley
Mytheresa initiated with an Overweight at Morgan Stanley
VRTX Vertex Pharmaceuticals
$211.97 /

+4.14 (+1.99%)

02/23/21 Baird
Baird upgrades Vertex Pharmaceuticals, shares attractive ahead of readouts
02/23/21 Baird
Vertex Pharmaceuticals upgraded to Outperform from Neutral at Baird
02/02/21 Credit Suisse
Vertex Pharmaceuticals price target lowered to $280 from $285 at Credit Suisse
02/02/21 BMO Capital
Vertex Pharmaceuticals price target lowered to $284 from $302 at BMO Capital
AVGO Broadcom
$449.96 /

+6.555 (+1.48%)

03/05/21 JPMorgan
Broadcom price target raised to $570 from $500 at JPMorgan
03/05/21 Morgan Stanley
Broadcom price target raised to $538 from $521 at Morgan Stanley
03/05/21 RBC Capital
Broadcom price target raised to $460 from $450 at RBC Capital
03/05/21 Wells Fargo
Broadcom price target raised to $450 from $410 at Wells Fargo
CSCO Cisco
$46.22 /

+1.595 (+3.57%)

03/05/21
Fly Intel: Top five analyst upgrades
03/05/21 JPMorgan
JPMorgan upgrades Cisco on spending recovery, 'inexpensive' valuation
03/05/21 JPMorgan
Cisco upgraded to Overweight from Neutral at JPMorgan
02/11/21 DZ Bank
Cisco upgraded to Buy from Hold at DZ Bank
QCOM Qualcomm
$129.75 /

+2.0799 (+1.63%)

03/04/21
Fly Intel: Top five analyst upgrades
03/04/21 JPMorgan
Qualcomm price target lowered to $170 from $185 at JPMorgan
03/04/21 Piper Sandler
Qualcomm upgraded to Overweight from Neutral at Piper Sandler
02/10/21 JPMorgan
China mobile shipments data point to 'robust' Apple demand, says JPMorgan
TXN Texas Instruments
$167.83 /

+4.58 (+2.81%)

02/23/21
Fly Intel: Top five analyst upgrades
02/23/21 Raymond James
Texas Instruments upgraded to Outperform from Market Perform at Raymond James
02/23/21 Raymond James
Texas Instruments upgraded to Outperform from Market Perform at Raymond James
01/29/21 Jefferies
Carvana, Walmart among 13 additions to Jefferies Franchise Picks list
VRTX Vertex Pharmaceuticals
$211.97 /

+4.14 (+1.99%)

TXN Texas Instruments
$167.83 /

+4.58 (+2.81%)

QCOM Qualcomm
$129.75 /

+2.0799 (+1.63%)

MSFT Microsoft
$231.58 /

+4.72 (+2.08%)

LOW Lowe's
$158.56 /

+4.865 (+3.17%)

GE General Electric
$13.59 /

+0.03 (+0.22%)

DIS Disney
$189.90 /

+2.18 (+1.16%)

CSCO Cisco
$46.22 /

+1.595 (+3.57%)

AVGO Broadcom
$449.96 /

+6.555 (+1.48%)

AER AerCap
$50.82 /

+0.825 (+1.65%)

  • 21
    Jan
VRTX Vertex Pharmaceuticals
$211.97 /

+4.14 (+1.99%)

QCOM Qualcomm
$129.75 /

+2.0799 (+1.63%)

MYTE Mytheresa
$27.08 /

+1.9 (+7.55%)

MSFT Microsoft
$231.58 /

+4.72 (+2.08%)

LOW Lowe's
$158.56 /

+4.865 (+3.17%)

GE General Electric
$13.59 /

+0.03 (+0.22%)

DIS Disney
$189.90 /

+2.18 (+1.16%)

CSCO Cisco
$46.22 /

+1.595 (+3.57%)

AVGO Broadcom
$449.96 /

+6.555 (+1.48%)

VRTX Vertex Pharmaceuticals
$211.97 /

+4.14 (+1.99%)

TXN Texas Instruments
$167.83 /

+4.58 (+2.81%)

QCOM Qualcomm
$129.75 /

+2.0799 (+1.63%)

MYTE Mytheresa
$27.08 /

+1.9 (+7.55%)

MSFT Microsoft
$231.58 /

+4.72 (+2.08%)

LOW Lowe's
$158.56 /

+4.865 (+3.17%)

GE General Electric
$13.59 /

+0.03 (+0.22%)

DIS Disney
$189.90 /

+2.18 (+1.16%)

CSCO Cisco
$46.22 /

+1.595 (+3.57%)

AVGO Broadcom
$449.96 /

+6.555 (+1.48%)

VRTX Vertex Pharmaceuticals
$211.97 /

+4.14 (+1.99%)

TXN Texas Instruments
$167.83 /

+4.58 (+2.81%)

QCOM Qualcomm
$129.75 /

+2.0799 (+1.63%)

MSFT Microsoft
$231.58 /

+4.72 (+2.08%)

LOW Lowe's
$158.56 /

+4.865 (+3.17%)

GE General Electric
$13.59 /

+0.03 (+0.22%)

DIS Disney
$189.90 /

+2.18 (+1.16%)

CSCO Cisco
$46.22 /

+1.595 (+3.57%)

AVGO Broadcom
$449.96 /

+6.555 (+1.48%)

Periodicals
MyTheresa stock might be cheapest thing it sells, Barron's says » 12:01
03/06/21
03/06
12:01
03/06/21
12:01
MYTE

Mytheresa

$27.08 /

+1.9 (+7.55%)

Mytheresa stock -…

Mytheresa stock - technically an American depositary share of parent company MYT Netherlands Parent - was recently trading just below its $26 initial-public-offering price after having jumped to $36 shortly after the debut, Nicholas Jasinski writes in this week's edition of Barron's. The stock could recover those losses and more in the coming months, the author contends, noting that while luxury buyer might have been slower to adopt e-commerce, the overall luxury market is growing by about 7% annually. Reference Link

ShowHide Related Items >><<
MYTE Mytheresa
$27.08 /

+1.9 (+7.55%)

MYTE Mytheresa
$27.08 /

+1.9 (+7.55%)

02/16/21
Fly Intel: Top five analyst initiations
02/16/21 Jefferies
Mytheresa initiated with a Buy at Jefferies
02/16/21 Credit Suisse
Mytheresa initiated with an Outperform at Credit Suisse
02/16/21 Morgan Stanley
Mytheresa initiated with an Overweight at Morgan Stanley
  • 21
    Jan
MYTE Mytheresa
$27.08 /

+1.9 (+7.55%)

Initiation
Fly Intel: Top five analyst initiations » 09:53
02/16/21
02/16
09:53
02/16/21
09:53
BEAM

Beam Therapeutics

$106.00 /

+1 (+0.95%)

, CURI

CuriosityStream

$19.70 /

+0.92 (+4.90%)

, LOTZ

CarLotz

$9.40 /

+0.3 (+3.30%)

, CRWD

Crowdstrike

$247.96 /

+5.85 (+2.42%)

, MYTE

Mytheresa

$32.60 /

+1.2 (+3.82%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Beam Therapeutics (BEAM) initiated with an Overweight at Wells Fargo. 2. CuriosityStream (CURI) initiated with a Buy at Roth Capital. 3. CarLotz (LOTZ) initiated with an Outperform at William Blair. 4. Crowdstrike (CRWD) initiated with a Buy at Canaccord. 5. Mytheresa (MYTE) initiated with an Outperform at Cowen and Credit Suisse, initiated with an Overweight at JPMorgan and Morgan Stanley, and initiated with a Buy at Jefferies. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
MYTE Mytheresa
$32.60 /

+1.2 (+3.82%)

LOTZ CarLotz
$9.40 /

+0.3 (+3.30%)

CURI CuriosityStream
$19.70 /

+0.92 (+4.90%)

CRWD Crowdstrike
$247.96 /

+5.85 (+2.42%)

BEAM Beam Therapeutics
$106.00 /

+1 (+0.95%)

BEAM Beam Therapeutics
$106.00 /

+1 (+0.95%)

02/16/21 Wells Fargo
Beam Therapeutics initiated with an Overweight at Wells Fargo
01/29/21 JPMorgan
Beam downgraded to Neutral with $100 target at JPMorgan
01/29/21 JPMorgan
Beam Therapeutics downgraded to Neutral from Overweight at JPMorgan
01/05/21 Stifel
Beam Therapeutics initiated with a Hold at Stifel
CURI CuriosityStream
$19.70 /

+0.92 (+4.90%)

02/16/21 Roth Capital
CuriosityStream initiated with a Buy at Roth Capital
01/12/21 Benchmark
CuriosityStream initiated with a Buy at Benchmark
01/06/21 B. Riley
B. Riley downgrades CuriosityStream after 'puzzling' 95% stock rally
01/06/21 B. Riley
CuriosityStream downgraded to Neutral from Buy at B. Riley Securities
LOTZ CarLotz
$9.40 /

+0.3 (+3.30%)

02/16/21 William Blair
CarLotz initiated with an Outperform at William Blair
CRWD Crowdstrike
$247.96 /

+5.85 (+2.42%)

02/16/21 Canaccord
Crowdstrike initiated with a Buy at Canaccord
02/11/21 Oppenheimer
Crowdstrike assumed with an Outperform at Oppenheimer
01/27/21 Truist
Crowdstrike price target raised to $250 from $200 at Truist
01/25/21 Summit Insights
Crowdstrike upgraded to Buy from Sell at Summit Insights
MYTE Mytheresa
$32.60 /

+1.2 (+3.82%)

02/16/21 Jefferies
Mytheresa initiated with a Buy at Jefferies
02/16/21 Credit Suisse
Mytheresa initiated with an Outperform at Credit Suisse
02/16/21 Morgan Stanley
Mytheresa initiated with an Overweight at Morgan Stanley
02/16/21 JPMorgan
Mytheresa initiated with an Overweight at JPMorgan
CRWD Crowdstrike
$247.96 /

+5.85 (+2.42%)

BEAM Beam Therapeutics
$106.00 /

+1 (+0.95%)

  • 04
    Feb
  • 21
    Jan
  • 01
    Oct
  • 26
    Jun
CRWD Crowdstrike
$247.96 /

+5.85 (+2.42%)

MYTE Mytheresa
$32.60 /

+1.2 (+3.82%)

CURI CuriosityStream
$19.70 /

+0.92 (+4.90%)

CRWD Crowdstrike
$247.96 /

+5.85 (+2.42%)

BEAM Beam Therapeutics
$106.00 /

+1 (+0.95%)

LOTZ CarLotz
$9.40 /

+0.3 (+3.30%)

CURI CuriosityStream
$19.70 /

+0.92 (+4.90%)

CRWD Crowdstrike
$247.96 /

+5.85 (+2.42%)

BEAM Beam Therapeutics
$106.00 /

+1 (+0.95%)

Initiation
Mytheresa initiated with a Buy at Jefferies » 07:47
02/16/21
02/16
07:47
02/16/21
07:47
MYTE

Mytheresa

$31.55 /

-0.1 (-0.32%)

Jefferies analyst Flavio…

Jefferies analyst Flavio Cereda initiated coverage of Mytheresa with a Buy rating and $37 price target. The company is "the only pure Luxury multibrand digital platform currently listed" on the NYSE in a a segment of the sector that has "high barriers to entry and is a de facto oligopoly," Cereda tells investors. He sees Mytheresa being set to deliver compound annual revenue growth of 20%+ with "stable margins," Cereda added.

ShowHide Related Items >><<
MYTE Mytheresa
$31.55 /

-0.1 (-0.32%)

MYTE Mytheresa
$31.55 /

-0.1 (-0.32%)

02/16/21 Credit Suisse
Mytheresa initiated with an Outperform at Credit Suisse
02/16/21 Morgan Stanley
Mytheresa initiated with an Overweight at Morgan Stanley
02/16/21 JPMorgan
Mytheresa initiated with an Overweight at JPMorgan
02/16/21 Cowen
Mytheresa initiated with an Outperform at Cowen
  • 21
    Jan
MYTE Mytheresa
$31.55 /

-0.1 (-0.32%)

Initiation
Mytheresa initiated with an Outperform at Credit Suisse » 06:57
02/16/21
02/16
06:57
02/16/21
06:57
MYTE

Mytheresa

$31.55 /

-0.1 (-0.32%)

Credit Suisse analyst…

Credit Suisse analyst Michael Binetti initiated coverage of Mytheresa with an Outperform rating and $39 price target. Mytheresa is a Germany-based global digital luxury retailer selling the highest-priced products from greater than 200 top luxury brands to top-tier wealthy consumers, Binetti tells investors in a research note. The company has a small base of customers today at 568,000, but active customers are growing at the top of the digital retail peer group range, says the analyst. He sees the stock outperforming given the strong global luxury growth, the shift to digital channels and a "passionate" customer base.

ShowHide Related Items >><<
MYTE Mytheresa
$31.55 /

-0.1 (-0.32%)

MYTE Mytheresa
$31.55 /

-0.1 (-0.32%)

02/16/21 Morgan Stanley
Mytheresa initiated with an Overweight at Morgan Stanley
02/16/21 JPMorgan
Mytheresa initiated with an Overweight at JPMorgan
02/16/21 Cowen
Mytheresa initiated with an Outperform at Cowen
  • 21
    Jan
MYTE Mytheresa
$31.55 /

-0.1 (-0.32%)

Initiation
Mytheresa initiated with an Overweight at Morgan Stanley » 06:38
02/16/21
02/16
06:38
02/16/21
06:38
MYTE

Mytheresa

$31.55 /

-0.1 (-0.32%)

Morgan Stanley analyst…

Morgan Stanley analyst Kimberly Greenberger initiated coverage of Mytheresa with an Overweight rating and $37 price target. Luxury e-commerce is "one of the most attractive high-growth Softlines sub-segments," said Greenberger, who is constructive on the company's carefully edited product selection and loyal customer base of everyday luxury shoppers. She forecasts revenue growth for Mytheresa at least in-line with the "attractive" 23% 2014-25 compound annual growth rate she sees for the overall luxury e-commerce market, the analyst tells investors.

ShowHide Related Items >><<
MYTE Mytheresa
$31.55 /

-0.1 (-0.32%)

MYTE Mytheresa
$31.55 /

-0.1 (-0.32%)

02/16/21 JPMorgan
Mytheresa initiated with an Overweight at JPMorgan
02/16/21 Cowen
Mytheresa initiated with an Outperform at Cowen
  • 21
    Jan
MYTE Mytheresa
$31.55 /

-0.1 (-0.32%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.